摘要
膳食抗氧化剂在与氧化应激相关的障碍,尤其是神经退行性疾病的治疗应用方面,其对靶器官、组织、细胞的功效、细胞摄取和将抗氧化剂特定的特殊转运仍然是面临的最重要的难题;如而脑靶向性仍是一项未解决的挑战。纳米技术给药投递系统可以解决上面提到的问题,特别是以神经保护活性的膳食抗氧化剂为的靶向投递。纳米技术给药系统可以防止抗氧化剂的降解,并且改善他们的药物理化性质及他们的生物利用度。 本文突出强调了纳米医学在改善膳食抗氧化剂方面的影响,如 氧化应激抗氧化剂 , 尤其是通过利用使用药物投递系统的抗氧化剂;,及以及通常常规的以给药为目的纳米材料类型。 根据这些材料,我们推断出抗氧化剂(膳食)和纳米技术联用的研究,也就是神经退行性疾病的治疗方法,仍然处于初期阶段。因此,大更广泛的研究领域仍需研究,希望在可预见的时期,能够研究出新的、有效的神经保护治疗剂。
关键词: 膳食抗氧化剂,纳米载体,神经退行性疾病,氧化应激相关疾病
Current Medicinal Chemistry
Title:Nanotechnology and Antioxidant Therapy: An Emerging Approach for Neurodegenerative Diseases
Volume: 21 Issue: 38
Author(s): Carlos Fernandes, Catarina Oliveira, Sofia Benfeito, Pedro Soares, Jorge Garrido and Fernanda Borges
Affiliation:
关键词: 膳食抗氧化剂,纳米载体,神经退行性疾病,氧化应激相关疾病
摘要: The efficacy, cellular uptake and specific transport of dietary antioxidants to target organs, tissues and cells remains the most important setback for their application in the treatment of oxidative-stress related disorders and in particular in neurodegenerative diseases, as brain targeting remains a still unsolved challenge. Nanotechnology based delivery systems can be a solution for the above mentioned problems, specifically in the case of targeting dietary antioxidants with neuroprotective activity. Nanotechnology-based delivery systems can protect antioxidants from degradation, improve their physicochemical drug-like properties and in turn their bioavailability.
The impact of nanomedicine in the improvement of the performance of dietary antioxidants, as protective agents in oxidative- stress events, specifically through the use of drug delivery systems, is highlighted in this review as well as the type of nanomaterials regularly used for drug delivery purposes.
From the data one can conclude that the research combining (dietary) antioxidants and nanotechnology, namely as a therapeutic solution for neurodegenerative diseases, is still in a very early stage. So, a huge research area remains to be explored that hopefully will yield new and effective neuroprotective therapeutic agents in a foreseeable future.
Export Options
About this article
Cite this article as:
Fernandes Carlos, Oliveira Catarina, Benfeito Sofia, Soares Pedro, Garrido Jorge and Borges Fernanda, Nanotechnology and Antioxidant Therapy: An Emerging Approach for Neurodegenerative Diseases, Current Medicinal Chemistry 2014; 21 (38) . https://dx.doi.org/10.2174/0929867321666140915141836
DOI https://dx.doi.org/10.2174/0929867321666140915141836 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Diabetic Vasculopathy and the Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 (LOX-1)
Current Diabetes Reviews Hydroximic Acid Derivatives: Pleiotropic Hsp Co-Inducers Restoring Homeostasis and Robustness
Current Pharmaceutical Design Treatments for Obesity-Related Hypertension
Current Hypertension Reviews The Ryanodine Receptor: A Pivotal Ca2+ Regulatory Protein and Potential Therapeutic Drug Target
Current Drug Targets Development and Optimization of Self-emulsifying Drug Delivery Systems (SEDDS) for Enhanced Dissolution and Permeability of Rosuvastatin
Current Drug Delivery Emerging Approved Treatments for Idiopathic Pulmonary Fibrosis: Some Hope for Patients?
Current Respiratory Medicine Reviews Advantages and Limitations of Transgenic Mice: The Role of the Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger in Cardiac Electrophysiology and Arrhythmia
Current Medicinal Chemistry Evaluation of Echocardiographic Abnormalities in HIV Positive Patients Treated with Antiretroviral Medications
Infectious Disorders - Drug Targets Editorial [Hot topic:Vascular Protective Effects of Ezetimibe: Seeking New Therapeutic Possibilities of Ezetimibe in Vascular Disease (Guest Editor: Minako Yamaoka-Tojo)]
Current Vascular Pharmacology Managing Safety Signals in Large Endpoint Trials
Current Drug Safety Testosterone Deficiency in Male: A Risk Factor for Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets The Involvement of Lysosomes in Myocardial Aging and Disease
Current Cardiology Reviews Anti-Atherosclerotic Molecules Targeting Oxidative Stress and Inflammation
Current Pharmaceutical Design Mutations of Nuclear and Mitochondrial Genomes as Potential Targets for the Treatment of Metabolic Syndrome
Current Pharmaceutical Design Editorial [Hot Topic: Pharmacogenomics: Achievements, Challenges and Prospects, for Patients, Pharmaceutical Industries and Healthcare Systems (Guest Editor: Despina Sanoudou)]
Current Pharmaceutical Design Targeting Cancer Stem Cell Lines as a New Treatment of Human Cancer
Recent Patents on Anti-Cancer Drug Discovery Hypertension and Diabetes: Emphasis on the Renin – Angiotensin System and Insulin Resistance
Current Hypertension Reviews Fructooligosaccharides of Edible Alliums: Occurrence, Chemistry and Health Benefits
Current Nutrition & Food Science Critical Review of Malondialdehyde Analysis in Biological Samples
Current Pharmaceutical Analysis Age-related Changes in Pharmacodynamics: Focus on Drugs Acting on Central Nervous and Cardiovascular Systems
Current Drug Metabolism